Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Investigation of Out-of-Trend (OOT) Results – V 2.0

Posted on By

Analytical Method Development: SOP for Investigation of Out-of-Trend (OOT) Results – V 2.0

Standard Operating Procedure for Investigation of Out-of-Trend (OOT) Results in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/349/2025
Supersedes SOP/AMD/349/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to establish a structured process for identifying, evaluating, and documenting Out-of-Trend (OOT) results observed during Analytical Method Development (AMD) activities. The goal is to

ensure data integrity, GMP compliance, and a robust scientific rationale for handling such events.

2. Scope

This SOP applies to all AMD studies conducted on raw materials, in-process samples, finished products, and stability samples wherein the result, although within specification, deviates from historical data or expected trends. It encompasses chromatographic, spectroscopic, titrimetric, and other analytical techniques.

3. Responsibilities

  • Analytical Scientist: Identifies and initiates investigation of OOT result.
  • AMD Supervisor: Reviews data and trends, assigns investigation ownership, and ensures timely closure.
  • QA Unit: Ensures compliance with investigation timelines and verifies scientific justifications.
  • Statistician (if applicable): Supports data trend analysis using statistical tools.
See also  Analytical Method Development: SOP for Method Verification for Pharmacopoeial Methods - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring all OOT results are appropriately investigated and documented, maintaining data quality and compliance with regulatory expectations such as ICH Q10 and WHO TRS guidelines.

5. Procedure

5.1 Identification of OOT Result

  1. OOT result is flagged when the analytical result, although within specification, shows a significant deviation from historical trend.
  2. Trend charts and control limits established in method development protocols are the primary reference.
  3. OOT may be observed in assay, dissolution, impurities, pH, viscosity, or other measured parameters.

5.2 Initial Verification and Documentation

  1. Analyst shall halt further processing and inform the AMD supervisor immediately.
  2. Fill Annexure-1: OOT Notification and Verification Form with initial observations.
  3. Repeat analysis only if allowed per SOP, and only after preliminary approval by the supervisor.

5.3 Investigation Process

  1. Use the structured RCA format in Annexure-2 for investigating potential causes.
  2. Check for analyst error (sample handling, dilution, instrument setup, transcription mistake).
  3. Evaluate instrument performance logs (calibration, maintenance, system suitability).
  4. Assess reagent integrity, environmental conditions, and method parameters.

5.4 Categorization of OOT

  • Assignables: Errors due to instrument malfunction, incorrect preparation, contamination, etc.
  • Non-Assignables: Root cause not identifiable; may require method robustness enhancement or risk-based conclusion.
See also  Analytical Method Development: Qualification of Method Development Instruments - V 2.0

5.5 Data Analysis and Trend Evaluation

  1. Review previous data sets of the same product/method to confirm trend boundaries.
  2. Apply statistical tools such as control charts, regression analysis, or moving average methods.
  3. Compare current result against historical means and standard deviations.

5.6 Corrective and Preventive Action (CAPA)

  1. Based on the investigation outcome, assign CAPA in Annexure-3.
  2. Examples: calibration schedule revision, retraining, environmental monitoring, SOP updates.
  3. Track closure timelines and responsible personnel for each action item.

5.7 Report Closure

  1. Summarize findings, trend data, statistical evaluation, and CAPA in the final OOT Investigation Report (Annexure-4).
  2. QA shall review and approve closure after verifying completeness and compliance.
  3. Archive report in AMD quality documentation repository with traceable report ID.

6. Abbreviations

  • OOT: Out-of-Trend
  • RCA: Root Cause Analysis
  • CAPA: Corrective and Preventive Action
  • QA: Quality Assurance
  • AMD: Analytical Method Development

7. Documents

  1. Annexure-1: OOT Notification and Verification Form
  2. Annexure-2: OOT Investigation RCA Worksheet
  3. Annexure-3: CAPA Summary Log
  4. Annexure-4: OOT Investigation Closure Report

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • ICH Q9 – Quality Risk Management
  • WHO TRS 996 Annex 7 – GMP for Pharmaceutical Products
  • 21 CFR Part 211 – cGMP Regulations
See also  Analytical Method Development: QbD-Based Method Development Approach - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Karan Mehta Dr. Priya Deshmukh Dr. Nilesh Sawant
Designation Analyst QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: OOT Notification and Verification Form

Includes sample ID, method, result observed, expected trend range, instrument details, analyst remarks, and supervisor initials.

Annexure-2: OOT Investigation RCA Worksheet

Used to structure the root cause evaluation, covering potential sources such as material, method, machine, man, and environment.

Annexure-3: CAPA Summary Log

CAPA ID Description Assigned To Target Date Status
CAPA-OOT-349-01 Recalibration of UV-Vis Spectrophotometer Engineering 05/06/2025 Completed

Annexure-4: OOT Investigation Closure Report

Summarizes the full investigation, outcome, statistical justifications, and CAPA status. Reviewed and approved by QA Head.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Included trend charts and statistical tools Annual SOP Review Dr. Nilesh Sawant
20/04/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Change Control Procedure – V 2.0
Next Post: Analytical Method Development: SOP for Control and Archival of Chromatographic Data – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version